Board Resignations and Appointments at Maravai LifeSciences Holdings, Inc.

On October 21, 2025, Maravai LifeSciences Holdings, Inc. announced the voluntary resignations of three directors: Benjamin Daverman, Jessica Hopfield, PhD, and Murali Prahalad, PhD. These resignations were part of the company's efforts to rationalize the size of its Board of Directors and reduce administrative costs. The Board size was reduced from eleven to eight directors, effective October 27, 2025. The resignations were not related to any disagreements with the company's management, Board, or any committee. In recognition of their service, the Board accelerated the vesting of all unvested restricted stock unit awards held by the departing directors. Additionally, R. Andrew Eckert was appointed chair of the Nominating, Governance and Risk Committee and as a member of the Audit Committee, and Gregory T. Lucier was appointed as a member of the Nominating, Governance and Risk Committee.